Taro recalls Clobetasol Ointment with R. Pickettii bacteria risk
Taro Pharmaceuticals recalls 0.05% Clobetasol Propionate Ointment tubes due to R. Pickettii bacterial contamination. Stop using if you have the recalled lot numbers.
Recall notice
Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria
Contact the company
What happened, in plain English
Taro Pharmaceuticals is recalling 0.0:5% Clobetasol Propionate Ointment tubes because they contain R. Pickettii bacteria. This contamination could cause infection in people using the ointment for medical purposes. Read more at govinfonow.com/recall/35423-taro-recalls-clobetasol-ointment-with-r-pickettii-bacteria-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/35423-taro-recalls-clobetasol-ointment-with-r-pickettii-bacteria-risk · Updated August 18, 2026 · FDA enforcement record: FDA #D-0375-2022
Cite this page
“Taro recalls Clobetasol Ointment with R. Pickettii bacteria risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35423-taro-recalls-clobetasol-ointment-with-r-pickettii-bacteria-risk. Based on FDA recall #D-0375-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0375-2022%22&limit=1).
Why it’s dangerous
The ointment contains R. Pickettii bacteria, which can cause infections. This is a risk for people using the product for medical purposes, especially those with weakened immune systems.
Who’s affected
People with prescriptions for this ointment are affected. Those using it for skin conditions are at risk of infection.
How to tell if you have this one
Check for the product name 'Clobetasol Propionate Ointment USP 0.05% 60g tubes'. Look for lot number AC13786 and expiration date DEC 2022 on the tube.
- Brand
Taro- Category
Drug
What to do — step by step
Check Product Details
Look for lot number AC13786 and expiration date DEC 2022 on the tube.
Where it went and when
Where it was distributed
Distributed nationwide; the notice names 2 states.
FDA distribution: “Two distributors in UT and LA who could have further distributed to the retail level nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Louisiana, Utah.
Recall timeline
FDA terminated this recall 2 years after the firm started it.
- Firm started the recall
- FDA classified it Class I
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0375-2022 (December 15, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0375-2022 to see it in context.
- Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.